Biological Drug candidate HAS2021 is based on Primecell´s fifteen years experience with cell and tissue products and extraordinary orthopedics outputs of University hospital in Prague.
Cytokine Bioscience is a spin-off of Primecell´s research labs 4MEDi and NATIC, similarly as a spin-off Biohealing(2018).
Research of HAS2021 was granted by the Technology Agency of the Czech Republic, ID Trend1/FW01010339 in 2019.
Project INNOBOOSTER: Global Business Development Officer is co-financed by the Moravian-Silesian Region within the framework of the grant program Support for Entrepreneurship in the Moravian-Silesian Region 2022.